International Assets Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

International Assets Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162K	Sell	326 -100	-23%	-$44.3K	0.01%	933
2026 Q1	$191K	Buy	426 +16	+4%	+$7.46K	0.01%	819
2025 Q4	$186K	Sell	410 -88	-18%	-$37.9K	0.01%	834
2025 Q3	$225K	Hold	498	–	–	0.02%	712
2025 Q2	$222K	Sell	498 -55	-10%	-$25.3K	0.02%	722
2025 Q1	$268K	Sell	553 -83	-13%	-$38.7K	0.02%	608
2024 Q4	$258K	Sell	636 -323,990	-100%	-$150M	0.02%	635
2024 Q3	$698	Buy	324,626 +324,188	+74,016%	+$156M	﹤0.01%	1254
2024 Q2	$205K	Buy	+438	New	+$190K	0.02%	698
2023 Q2	–	Sell	-518	Closed	-$163K	–	1107
2023 Q1	$163K	Buy	+518	New	+$155K	0.02%	516
2021 Q2	–	Sell	-769	Closed	-$172K	–	1870
2021 Q1	$172K	Buy	769 +442	+135%	+$97.1K	0.02%	550
2020 Q4	$77K	Buy	+327	New	+$75K	0.01%	687

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

International Assets Investment Management's VRTX Position: Q2 2026 in Review

International Assets Investment Management reduced its Vertex Pharmaceuticals (VRTX) stake by 23% in Q2 2026, selling an estimated $44.3K and leaving 326 shares worth $162K. The position accounts for 0.01% of the portfolio, ranked #933.

International Assets Investment Management first reported a position in VRTX in Q4 2020 and has held it in 12 quarters since. The position peaked at $268K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

International Assets Investment Management held 326 shares of Vertex Pharmaceuticals worth $162K as of Q2 2026.
International Assets Investment Management sold 100 Vertex Pharmaceuticals shares in Q2 2026, an estimated $44.3K.
Vertex Pharmaceuticals made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #933 holding.
International Assets Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
International Assets Investment Management's Vertex Pharmaceuticals position peaked at $268K in Q1 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.